0001123292-19-000752.txt : 20190513 0001123292-19-000752.hdr.sgml : 20190513 20190513193302 ACCESSION NUMBER: 0001123292-19-000752 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190513 FILED AS OF DATE: 20190513 DATE AS OF CHANGE: 20190513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHANNON TIMOTHY M CENTRAL INDEX KEY: 0001207114 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38905 FILM NUMBER: 19820102 MAIL ADDRESS: STREET 1: C/O CURAGEN CORP STREET 2: 555LONG WHARF DR. 11TH FL. CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NextCure, Inc. CENTRAL INDEX KEY: 0001661059 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475231247 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD, SUITE 200 CITY: BELTSVILLE STATE: MD ZIP: 20705 BUSINESS PHONE: 240-399-4900 MAIL ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD, SUITE 200 CITY: BELTSVILLE STATE: MD ZIP: 20705 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-05-13 0001661059 NextCure, Inc. NXTC 0001207114 SHANNON TIMOTHY M C/O CANAAN PARTNERS 285 RIVERSIDE AVENUE, SUITE 250 WESTPORT CT 06880 1 0 0 0 Common Stock 2019-05-13 4 C 0 445866 A 445866 I See footnote Common Stock 2019-05-13 4 C 0 743110 A 1188976 I See footnote Common Stock 2019-05-13 4 C 0 729599 A 1918575 I See footnote Common Stock 2019-05-13 4 C 0 285867 A 2204442 I See footnote Common Stock 2019-05-13 4 P 0 50000 15.00 A 2254442 I See footnote Series A-1 Preferred Stock 2019-05-13 4 C 0 3582000 D Common Stock 445866 0 I See footnote Series A-2 Preferred Stock 2019-05-13 4 C 0 5970000 D Common Stock 743110 0 I See footnote Series A-3 Preferred Stock 2019-05-13 4 C 0 5861455 D Common Stock 729599 0 I See footnote Series B-1 Preferred Stock 2019-05-13 4 C 0 2296605 D Common Stock 285867 0 I See footnote The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date. The reported securities are held directly by Canaan X L.P. (the "Canaan Fund"). The sole general partner of the Canaan Fund is Canaan Partners X LLC ("Canaan X", and together with the Canaan Fund, the "Canaan Entities"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. The Reporting Person, a manager and member of Canaan X, serves as the representative of the Canaan Entities on the Issuer's board of directors. The Reporting Person disclaims Section 16 beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest therein, if any, in such securities by virtue of the limited liability company interest he owns in Canaan X. Exhibit 24 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24 to the Form 3 filed by the Reporting Person on May 8, 2019) /s/ Janine MacDonald, Attorney-in-Fact for Timothy M. Shannon 2019-05-13